Dietary supplement compositions are provided herein. Also provided herein arc methods for using the dietary supplement compositions as pre-workout supplements or as supplements during a workout.
A61K 36/31 - Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
This document provides dietary supplement compositions. For example, dietary supplement compositions containing leucine, isoleucine, valine, lysine, phenylalanine, threonine, histidine, methionine, tryptophan, and tart cherry are provided herein. Also provided herein are methods for using the compositions to enhance post-workout recovery.
Provided herein is a beverage composition that includes particular collagen peptides. The beverage compositions described herein can be ingested to improve the health of skin, joints, and/or hair. In one aspect, powdered beverage compositions are provided that include first collagen peptides, second collagen peptides, and axtaxanthin, wherein the first collagen peptides have an average molecular weight of about 1 kDa to about 4 kDa and the second collagen peptides have an average molecular weight of about 2 kDa to about 5 kDa.
Brain health supplement compositions are described herein. For example, this document provides brain health supplement compositions containing phosphatidylserine, a Ginkgo biloba extract, and a Bacopa monnieri extract.
A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
This document provides dietary supplement compositions. For example, dietary supplement compositions having beta glucan, quercetin, and one or more of vitamin A, vitamin C, vitamin D, and zinc are provided herein.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
This document provides dietary supplement compositions. For example, dietary supplement compositions having beta glucan, quercetin, and one or more of vitamin A, vitamin C, vitamin D, and zinc are provided herein.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
9.
COMPOSITIONS CONTAINING COATED MINERALS OR MINERAL-AMINO ACID COMPLEXES
This document provides compositions containing mineral-amino acid/ polysaccharide complexes, where at least one of the complexes in the composition has a slow release coating, and in some cases, other complexes in the composition do not have a slow release coating. This document also provides and methods of making and using the complexes and the compositions.
This document provides compositions containing mineral-amino acid/polysaccharide complexes, where at least one of the complexes in the composition has a slow release coating, and in some cases, other complexes in the composition do not have a slow release coating. This document also provides and methods of making and using the complexes and the compositions.
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
12.
DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING
Melaleuca (Nantong) Wellness Science and Technology Co., Ltd. (China)
Inventor
Bu, Bruce
Gutierrez, Ricardo
Ge, Gerry
Abstract
This document provides dietary supplement compositions. For example, this document provides dietary supplement compositions that include a Ganoderma lucidum extract.
Materials and methods for formulating a baby wash/shampoo are provided herein. For example, this document provides materials and methods for formulating a foaming baby wash/shampoo compositions that contain natural ingredients and are not irritating to babies' skin and eyes.
Materials and methods for formulating skin care compositions suitable for use on babies and toddlers are provided herein. For example, this document provides materials and methods for formulating diaper cream compositions that contain natural ingredients, are not irritating to babies' skin, and can be used to treat or prevent symptoms of diaper rash.
Materials and methods for formulating skin care compositions suitable for use on babies and toddlers are provided herein. For example, this document provides materials and methods for formulating lotion compositions that contain natural ingredients, are not irritating to babies' skin, and can be used to moisturize and soothe dry skin.
Materials and methods for formulating skin care compositions suitable for use on babies and toddlers are provided herein. For example, this document provides materials and methods for formulating lotion compositions that contain natural ingredients, are not irritating to babies' skin, and can be used to moisturize and soothe dry skin.
Materials and methods for formulating skin care compositions suitable for use on babies and toddlers are provided herein. For example, this document provides materials and methods for formulating diaper cream compositions that contain natural ingredients, are not irritating to babies' skin, and can be used to treat or prevent symptoms of diaper rash.
A61K 31/231 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
Materials and methods for formulating a baby wash/shampoo are provided herein. For example, this document provides materials and methods for formulating a foaming baby wash/shampoo compositions that contain natural ingredients and are not irritating to babies' skin and eyes.
This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/205 - Amine addition salts of organic acidsInner quaternary ammonium salts, e.g. betaine, carnitine
A61K 31/385 - Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
A61K 31/435 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
A61K 33/06 - Aluminium, calcium or magnesiumCompounds thereof
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
This document provides bacterial compositions. For example, bacterial compositions having a combination of different bacterial strains formulated in a manner to maintain the stability of the bacteria are provided.
A61K 31/221 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
This document provides dietary supplements. For example, composition having a combination of ingredients useful in reducing cholesterol and improving overall cardiovascular health as well as methods for reducing cholesterol and improving overall cardiovascular health are provided.
A61K 31/575 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A23L 33/11 - Plant sterols or derivatives thereof, e.g. phytosterols
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
A61K 31/385 - Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
A61K 31/232 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 9/00 - Medicinal preparations characterised by special physical form
The document provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis. The document also provides methods for reducing pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis.
This document provides skin care compositions that can include one or more saponin extracts. In some cases, the skin care compositions provided herein can include a saponin extract (e.g., a Sapindus mukorossi extract). In some cases, the skin care compositions provided herein can include a Sapindus mukorossi extract, allantoin, carnosine, and a plant extract blend. The plant extract blend can include bioflavonoids (e.g., citrus bioflavonoids), a Brassica oleracea ver. italica (i.e., broccoli) extract, and an Aloe barbadensis leaf extract, or combinations thereof.
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A23L 33/16 - Inorganic salts, minerals or trace elements
A23L 33/115 - Fatty acids or derivatives thereofFats or oils
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
This disclosure relates to powdered automatic dishwashing detergents. More particularly, this disclosure relates to powdered automatic dishwashing detergent packets with superior environmental and human safety as well as superior cleaning efficacy and stability.
This invention provides bacterial compositions. For example, bacterial compositions having a combination of different bacterial strains formulated in a manner to maintain the stability of the bacteria are provided. In some embodiments, methods and materials provided herein can be used to deliver an effective and live dose of probiotics, to protect the probiotics during shelf life storage, and/or to achieve gastrointestinal bioavailability.
This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.
This document provides bacterial compositions. For example, bacterial compositions having a combination of different bacterial strains formulated in a manner to maintain the stability of the bacteria are provided.
This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/205 - Amine addition salts of organic acidsInner quaternary ammonium salts, e.g. betaine, carnitine
A61K 31/385 - Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
A61K 31/435 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
A61K 33/06 - Aluminium, calcium or magnesiumCompounds thereof
This invention provides bacterial compositions. For example, bacterial compositions having a combination of different bacterial strains formulated in a manner to maintain the stability of the bacteria are provided. In some embodiments, methods and materials provided herein can be used to deliver an effective and live dose of probiotics, to protect the probiotics during shelf life storage, and/or to achieve gastrointestinal bioavailability.
This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.
A61K 31/4748 - QuinolinesIsoquinolines forming part of bridged ring systems
A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K 31/221 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.
A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K 31/221 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
Provided herein are methods and materials for assessing platelet activity and/or the ability of substances (e.g., small molecule compounds and compositions comprising the same) to inhibit or activate platelet activity. For example, this document provides methods and materials that can include (a) applying abnormal flow conditions (e.g., oscillatory shear stress) to a sample of platelets (e.g., a blood sample or platelet-rich plasma sample) to stimulate the platelets, and (b) assessing the activity of the platelets. In some embodiments, the activity of the platelets can be assessed by measuring the amount of superoxide radial or the rate and/or level of platelet aggregation within the sample.
Provided herein are methods and materials for assessing platelet activity and/or the ability of substances (e.g., small molecule compounds and compositions comprising the same) to inhibit or activate platelet activity. For example, this document provides methods and materials that can include (a) applying abnormal flow conditions (e.g., oscillatory shear stress) to a sample of platelets (e.g., a blood sample or platelet-rich plasma sample) to stimulate the platelets, and (b) assessing the activity of the platelets. In some embodiments, the activity of the platelets can be assessed by measuring the amount of superoxide radial or the rate and/or level of platelet aggregation within the sample.
This disclosure relates to powdered automatic dishwashing detergents. More particularly, this disclosure relates to powdered automatic dishwashing detergent packets with superior environmental and human safety as well as superior cleaning efficacy and stability.
This disclosure relates to powdered automatic dishwashing detergents. More particularly, this disclosure relates to powdered automatic dishwashing detergent packets with superior environmental and human safety as well as superior cleaning efficacy and stability.
This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided.
A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A23L 1/304 - Inorganic salts, minerals, trace elements
A computer-implemented method for processing data in a database using a data cube is discussed and involves interacting with a user of a computing device, using a computer application, to obtain meta data about a database and obtain user-defined selections of options concerning the database; creating a data cube definition by using the selected options to identify characteristics of columns in the database; publishing to an OLAP engine a definition of a data cube that corresponds to the data base; generating a simplified flat-file model of the data in the data cube; and providing the simplified flat-file model in a form that can be reviewed and directly manipulated by the user.
A computer-implemented method for processing data in a database using a data cube is discussed and involves interacting with a user of a computing device, using a computer application, to obtain meta data about a database and obtain user-defined selections of options concerning the database; creating a data cube definition by using the selected options to identify characteristics of columns in the database; publishing to an OLAP engine a definition of a data cube that corresponds to the data base; generating a simplified flat-file model of the data in the data cube; and providing the simplified flat-file model in a form that can be reviewed and directly manipulated by the user.
This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided.
This document provides methods and materials related to hair care. For example, hair care compositions containing one or more quaternized polysiloxanes, one or more zwitterionic surfactants, one or more anionic surfactants, one or more botanical compounds, one or more amino acids, one or more vitamins, or any combination thereof as well as methods for using such hair care compositions are provided.
This document provides complexes comprising a mineral-amino acid compound and a polysaccharide. For example, the document provides compositions containing such complexes and methods of making and using such complexes.
This document relates to methods and materials for evaluating the anti-inflammatory response affected by substances on living cells in vitro or in vivo using electron paramagnetic resonance spectroscopy. For example, generation of ROS can be used as a measure of the effects of a compound on an induced inflammatory response in a biological sample.
G01N 33/49 - Physical analysis of biological material of liquid biological material blood
G01N 24/10 - Investigating or analysing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using electron paramagnetic resonance
G01N 27/62 - Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosolsInvestigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electric discharges, e.g. emission of cathode
Dietary compositions for enhancing feelings of satiety and thereby enhancing weight loss are disclosed herein. For example, dietary compositions containing a combination of beta glucan, whey protein, a natural protein extract derived from potatoes, and optionally inulin are provided.
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
This document provides dietary supplements. For example, compositions having a combination of ingredients useful in providing a broad scope of antioxidant protection for human or animal consumption are provided.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The document provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis. The document also provides methods for reducing pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis.
The document provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis. The document also provides methods for reducing pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis.
A61K 36/25 - Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
This document provides dietary supplements. For example, compositions having a combination of ingredients useful in providing a broad scope of antioxidant protection for human or animal consumption are provided.
This disclosure relates to ultra concentrated liquid laundry detergent (e.g., 3×+ ultra concentrated liquid laundry detergent). For example, this disclosure relates to ultra concentrated liquid laundry detergent having superior water dispersibility at low temperatures (e.g., from about 14° C. to about 19° C.).
This disclosure relates to ultra concentrated liquid laundry detergent (e.g., 3X+ ultra concentrated liquid laundry detergent). For example, this disclosure relates to ultra concentrated liquid laundry detergent having superior water dispersibility at low temperatures (e.g., from about 14° C to about 19° C).
This document provides complexes comprising a mineral-amino acid compound and a polysaccharide. For example, the document provides compositions containing such complexes and methods of making and using such complexes.
This document provides complexes comprising a mineral-amino acid compound and a polysaccharide. For example, the document provides compositions containing such complexes and methods of making and using such complexes.
This document provides complexes comprising a mineral-amino acid compound and a polysaccharide. For example, the document provides compositions containing such complexes and methods of making and using such complexes.
C08B 37/00 - Preparation of polysaccharides not provided for in groups Derivatives thereof
C07H 21/00 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Dietary compositions for enhancing feelings of satiety and thereby enhancing weight loss are disclosed herein. For example, dietary compositions containing a combination of beta glucan, whey protein, a natural protein extract derived from potatoes, and optionally inulin are provided.
Dietary compositions for enhancing feelings of satiety and thereby enhancing weight loss are disclosed herein. For example, dietary compositions containing a combination of beta glucan, whey protein, a natural protein extract derived from potatoes, and optionally inulin are provided.
A23J 1/12 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from cereals, wheat, bran, or molasses
Dietary supplements are disclosed herein. For example, dietary supplements containing a combination of tripeptides, potassium, pomegranate, and passionflower are provided.
A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Cleansing compositions for cleaning and/or disinfecting surfaces such as hard surfaces are provided, where a liquid cleansing and disinfecting composition in a concentrated form for dilution before use comprising sodium lauryl sulfate, citric acid, ammonium hydroxide, and thyme oil, wherein between 6 and 7 percent by weight, or between 1.5 and 2.5 percent on an active basis, of said liquid cleansing and disinfecting composition comprises said sodium lauryl sulfate, wherein between 3 and 5 percent of said liquid cleansing and disinfecting composition comprises said citric acid by weight, wherein between 0.7 and 0.8 percent, or between 0.2 and 0.23 percent on an ammonia basis, of said liquid cleansing and disinfecting composition comprises said ammonium hydroxide by weight, and wherein between 0.15 and 0.25 percent of said composition comprises said thyme oil by weight, wherein said liquid cleansing and disinfecting composition remains homogeneous for a period of at least 12 months when stored at 20.degree.C or for a period of at least three months when stored at 40.degree.C.
patents
